Ownership/ Partnership/ Principal. None None None Lantheus Medical Imaging (DSMB) NIH (DSMB)* None None None None None None
|
|
- Cameron Riley
- 5 years ago
- Views:
Transcription
1 AUTHOR RELATIONSHIPS WITH INDUSTRY AND OTHER ENTITIES (Comprehensive) ACCF/AHA 2013 GUIDELINE FOR THE MANAGEMENT OF ST-ELEVATION MYOCARDIAL INFARCTION (October, 2012) Committee Member Patrick T. O Gara, Chair Frederick G. Kushner, Vice Chair Deborah D. Ascheim Donald E. Casey, Jr. Mina K. Chung Employment Consultant Speaker s Bureau Harvard School Tulane School of Clinical ; Heart Clinic of Louisiana Director Mount Sinai School of Professor; InCHOIR Clinical Director of Research Atlantic Health Chief Officer and Vice President of Quality Cleveland Clinic Foundation Ownership/ Partnership/ Principal Personal Research Lantheus Imaging (DSMB) NIH (DSMB)* Institutional, Organizational or Other Financial Benefit American Heart Association Novartis Biotronik Boston Scientific Nexcura PGx Sanofi-aventis St. Jude Biosense Webster Biotronik Boston Scientific CardioDx CardioInsight GlaxoSmithKline Medtronic Boston Scientific Medtronic St. Jude Expert Witness
2 James A. de Lemos Steven M. Ettinger James C. Fang Francis B. Fesmire Barry A. Franklin Christopher B. Granger UT Southwestern School Penn State Heart and Vascular Institute and Radiology Hospitals Case Director, Heart Transplantation Heart Stroke Director William Beaumont Hospital Director, Cardiac Rehabilitation and Exercise Laboratories Duke Clinical Research Institute Director, Cardiac Care Unit; Assistant Johnson & Johnson Tethys BMS/Sanofi -aventis Siemens Solutions St. Jude Zin ZOLL Squibb (DSMB) Roche Astra-Zeneca Daiichi-Sankyo Thoratec Accorda Amgen NIH Novartis Paracor Medtronic Abbott Society of Chest Pain Centers (Board of Directors) Plaintiff, Missed ACS, 2010 AstraZeneca Boehringer Ingelheim* Squibb GlaxoSmithKline Hoffman La Astellas AstraZeneca Boehringer Ingelheim* Squibb Eli Lilly
3 Harlan M. Krumholz Jane A. Linderbaum David A. Morrow Yale School of Epidemiology and Public Health Mayo Clinic Assistant Harvard School Roche Novartis Otsuka Sanofi-aventis* The s Company Centegen/Life Tech United HealthCare (Science Advisory Group) GlaxoSmithKline Medtronic Merck Sanofi-aventis* The s Company American College of American Heart Association Massachusetts Society UnitedHealth VHA Beckman- Coulter Boehringer Ingelheim CardioKinetix CV Therapeutics/ Gilead Pharmaceuticals Critical Diagnostics Daiichi-Sankyo Genentech Ikaria Menarini Novartis OrthoClinical Diagnostics Roche Diagnostics Sanofi-aventis Schering-Plough Research Institute Siemens AstraZeneca Beckman-Coulter CV Therapeutics Daiichi-Sankyo Eli Lilly GlaxoSmithKline Merck Novartis Roche Diagnostics Sanofi-aventis Schering-Plough Research Institute Siemens Solutions Singulex AstraZeneca
4 L. Kristin Newby Joseph P. Ornato Narith Ou Martha J. Radford Jacqueline E. Tamis-Holland Duke Center, Division of Department of Emergency Virginia Commonwealth Professor and Chairman Mayo Clinic Pharmacotherapy Coordinator, NYU Langone Chief Quality Officer; NYU School of () St Luke's- Roosevelt Hospital Solutions Amgen* AstraZeneca BioVascular Shionogi Pharma NIH Resuscitation Outcomes Consortium ZOLL Circulation Amylin BG Squibb diadexus* Eli Lilly GlaxoSmithKline* Johnson & Johnson Merck* DCRI MURDOCK Study* NIH-NHLBI* Regado Schering Plough* NIH/NINDS Neurological Emergency Treatment Trials Consortium PI American Heart Association Elsevier/American Heart Journal Society of Chest Pain Centers Resuscitation
5 Carl L. Tommaso Cynthia M. Tracy Director, Interventional Fellowship Program; Columbia, College of Physicians and Surgeons Assistant Clinical Skokie Hospital Director of Catheterization Laboratory; NorthShore HealthSystems Partner George Washington Director, Division of Y. Joseph Woo Hospital of the of Pennsylvania Surgery David X. Zhao Vanderbilt Director, Cardiac Abbot Vascular Accumetrics AGA Osiris Volcano
6 Catheterization and Interventional This table represents all relationships of committee members with industry and other entities that were reported by authors, including those not deemed to be relevant to this document, at the time this document was under development. The table does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of 5% of the voting stock or share of the business entity, or ownership of $10,000 of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person s gross income for the previous year. Relationships that exist with no financial benefit are also included for the purpose of transparency. Relationships in this table are modest unless otherwise noted. *Indicates significant (>$10,000) relationship. Indicates no financial benefit. ACS indicates acute coronary syndromes; DSMB, data safety monitoring board; NHLBI, National Heart, Lung, and Blood Institute; NIH, National Institutes of Health; and PI, principal investigator.
HEARTS/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR/SNMMI 2014 Health Policy Statement on Use of Noninvasive Cardiovascular Imaging
Author Listing of Comprehensive Relationships With Industry and Other Entities for the ACCF/AHA/ASE/ASNC/HRS/IAC/MENDED HEARTS/NASCI/RSNA/SAIP/SCAI/SCCT/SCMR/SNMMI 2014 Health Policy Statement on Use of
More informationCommittee Member Employment Consultant Speaker s Bureau Ownership/ Partnership / Principal. Expert Witness
2013 ACCF/AHA/SCAI Clinical Competence Statement on Coronary Interventional Procedures (Revision of 2007 Statement) Online Author Listing of Comprehensive Relationships With Industry and Other Entities
More informationPlease complete the applicable rows in the following table. Monetary amounts are on an annual basis.
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): 2016 Name: Shelby D. Reed, PhD Title: Professor Address: PO Box 17969, Durham, NC 27715 Please complete the applicable rows in the following table.
More informationDCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report information for the calendar year 2014 and anticipated
More informationPlease complete the applicable rows in the following table. Monetary amounts are on an annual basis.
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): 2015 Name: Patrick Pun, MD Title: Asasistant Professor of Medicine Address: DCRI Please complete the applicable rows in the following table. Monetary
More informationDCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Duke COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the
More informationDCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Duke COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the
More informationDCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the calendar
More informationMethod of Declaration. Hospitality/Interest/Sponsorship
Hospitality/Interest/Sponsorship Date Received Method of Declaration Abbott Laboratories Limited 23/03/12 Sponsorship Abbott Laboratories Limited 28/05/12 Sponsorship Abbott Laboratories Limited 23/03/12
More information(3) Educational Activities or Lectures for this Company Generates Revenue for Duke $5K $25K >$25K
DCRI Commercial relationships Tracking Form Year: 2018 Name: Adrian Hernandez, M.D. Title: Vice Dean, Clinical, School of Medicine Address: 200 Trent Dr., Durham NC 27710 Please complete the applicable
More informationInstitutional, Organizational, or Other Financial. Ownership/ Partnership/Principa. Speakers Bureau. Reviewer Representation Employment Consultant
Relationships With Industry and Other Entities (Comprehensive) 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay (August 2018) Institutional,,
More informationPlease complete the applicable rows in the following table. Monetary amounts are on an annual basis.
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Year(s): Jan 2015 to December 2015 Name: Adam DeVore Title: Instructor in Medicine Address: 2400 Pratt Street, Durham, NC 27705 Please complete the applicable
More informationACC.13 Committee Disclosures Page 1 of 9
ACC.13 Program Committee Disclosures Last First Direcr Grants Alexander Karen P. Gilead Sanofi Aventis Ananthasu Karthikeya Lantheus Imaging bramaniam n Lantheus Imaging, Astellas Pharma US, Inc Astellas
More informationDCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM Duke COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the
More informationHeart Valve Summit: Medical, Surgical and Interventional Decision Making
Disclosure/Conflict of Interest Statement As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC), the American
More information2018 AATS/ACC/SCAI/STS
Reviewer Relationships With Industry and Other Entities (Comprehensive) 2018 AATS/ACC/SCAI/STS Expert Consensus Systems of Care Document: Operator and Institutional Requirements for Transcatheter Aortic
More informationReinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D
Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D John C. Lechleiter, Ph.D. Chairman, President, and Chief Executive Officer Eli Lilly and Company Washington Biotechnology &
More informationTHE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION)
THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION) Feedback from 93 Eastern-European patient groups PUBLISHED JULY 2016 CONTENTS ABOUT THIS REPORT Page 1 WHAT DID
More informationPrevious Attendees List:
Previous Attendees List: Company 3M Abbott Abbott Point of Care Abbott Vascular ACIST Medical ACIST Medical Systems Adamas Pharmaceuticals Aileron Holdings Allergan Allergan Allergan Ansell Healthcare
More information1. Your Identity. Photo. Treasurer. Application for the following position in the EHRA Board: Title: Prof, MD. Family Name(s): Pürerfellner
Photo Application for the following position in the EHRA Board: Treasurer 1. Your Identity Title: Prof, MD Family Name(s): Pürerfellner First Name(s): Helmut Friedrich Birth Date: 02-Apr-1961 Type of address:
More informationSZF Associates. SZF is an issues-oriented, evidence-based market research and consulting firm serving the pharmaceutical and biotech industry.
SZF Associates Company Mission SZF is an issues-oriented, evidence-based market research and consulting firm serving the pharmaceutical and biotech industry. We work with strategic and tactical decision
More informationDisclosures of Relevant Financial Relationships
Disclosures of Relevant Financial Relationships Disclosure Policy It is the policy of the Society of Cardiovascular Anesthesiologists (SCA) that the planners, faculty, and reviewers disclose the existence
More informationEarly Valuation. Company Portfolio
Early Valuation Company Portfolio The current strategy Idea PoC Regulatory Clinical Development Basic Science / Experts Operations Marketing / KOL Commercial Health Innovation Technology Transfer 1 I d
More informationCorporate Compliance & Transparency
4 th Annual Conference Corporate Compliance & Transparency in the Pharmaceutical Industry 24 25 February 2016 Zürich, Switzerland Conference In Numbers 84 Attendees 2 Days 29 Speakers 19 Participating
More informationACC.17 Program Committee Disclosures of Relationships With Industry Disclosures
ACC.17 Program Committee of Relationships With Industry Name Brian G. Abbott, MD, J. Dawn Abbott, MD, DATA SAFETY MONITORING BOARD - Pfizer Nazem Akoum, MD, CONSULTANT FEES/HONORARIA - Biotronik Karen
More informationEuropean companies outpace American counterparts in R&D investment growth for the first time in five years
IP/08/1504 Brussels, 15 October 2008 European companies outpace American counterparts in R&D investment growth for the first time in five years R&D investment by EU companies has increased by 8.8% compared
More informationGLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS
GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS PHM006K March 2016 Himani Singhi Wadhwa Project Analyst ISBN: 1-62296-254-0 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481
More informationThe 2011 EU industrial R&D investment SCOREBOARD
1 The 2011 EU industrial R&D investment SCOREBOARD Joint Research Centre European Commission Héctor Hernández Alex Tuebke Fernando Hervás 1. Background 2 Understanding the dynamics of industrial R&D at
More informationState of Licensing 2011 Update
State of Licensing 2011 Update Moderators/Speakers Hemmie Chang, Chair, Licensing & Strategic Alliance Practice Group, Foley Hoag LLP Ranya Dajani, Executive Director, Strategic Transactions Group, Bristol-
More informationSTEVEN W. ORLOW, MD, MMI, FACP, FACC
STEVEN W. ORLOW, MD, MMI, FACP, FACC Professional Summary I am a licensed physician executive with a master's degree followed by board certification in medical informatics and 7 years of Chief Medical
More informationAssociate Director. Biomarker Operations Lead. Business Development & Strategic Alliances. Business Development Executive
Job Title Alliance Lead Analytics Specialist Associate Director Associate Director Diagnostics Partnering Associate Director Business Development Associate Director Application Architecture Associate Manager
More informationTRANSLATIONAL SCIENCE
TRANSLATIONAL SCIENCE A Discussion of Best Practices and Unique Models Wednesday January 31, 2018 at The NYSCF Research Institute HRA TRI-STATE REGIONAL MEETING 31 Wednesday January, 2018 AGENDA 8:30 AM
More informationCommittee Disclosures Page 1 of 12
TCT@ACC-i2 Program Committee Disclosures Last Name First Name Middle Name Nothing to Grants Abbott J. Dawn X Abizaid Alexandre Abbott, Boston Scientific Angiolillo Dominick J. Eli Lilly, Daiichi-Sankyo,
More informationInnovation and the Changing Practice of Medicine
Innovation and the Changing Practice of Medicine Japan Medical Innovation Symposium David Epstein, Division Head Novartis Pharmaceuticals Tokyo, August 18, 2015 Agenda The Case for Innovation How Novartis
More information7th Annual Oncology Update A CME review of the 2010 ASCO Annual Meeting June August Exhibitor Prospectus. About the Course
7th Annual Oncology Update A CME review of the 2010 ASCO Annual Meeting June August 2010 Exhibitor Prospectus About the Course During Scripps Clinic s Oncology Update course, clinical experts will review
More informationTRENDS IN IP DISPUTES
ASSOCIATION OF CORPORATE COUNSEL LITIGATION COMMITTEE APRIL 25, 2017 TRENDS IN IP DISPUTES DAVID YURKERWICH MANAGING DIRECTOR IP PRACTICE LEADER 1 AGENDA Patent infringement and IPR filing trends Operating
More informationAnnual Benefit-Risk Workshop
Annual Benefit-Risk Workshop Implementing an Internationally Acceptable Framework for the Benefit- Risk Assessment of Medicines: How close are we to this objective? 20-21 June 2013 PROGRAMME Venue: The
More informationOther appointments: Chairman of the Advisory Committee of Zentiva Group, Industrial Advisor EQT.
Executive Committee Guido Oelkers Chief Executive Officer Born 1965. Employed since 2017. PhD in Strategic Management, University of South Australia, Master of Economics, South Bank University, London,
More informationAppendix 1. Participants in the ACCF/AHA Consensus Conference on Professionalism and Ethics
Appendix 1. Participants in the ACCF/AHA Consensus Conference on Professionalism and Ethics Conference Co-Chairs Dr. Richard Popp Acumen Medical Pelikan Technologies Percardia, Inc. Acumen Medical Agilent
More informationHESI Annual Meeting January 19, Welcome!!!! Meeting of the. HESI Assembly of Members. Dr. James MacDonald President of HESI 01/19/09
HESI Annual Meeting January 19, 2009 Welcome!!!! Meeting of the HESI Assembly of Members Dr. James MacDonald President of HESI The HESI logo... Depicts our commitment to the tripartite approach... Government!
More informationPROTECT Project. Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium
PROTECT Project Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium Content of Presentation About IAPO Overview of PROTECT Work Package 4 - New methods for data
More informationMidwestern Conference on Optimizing Electrophysiology Patient Care and Procedural
Midwestern Conference on Optimizing Electrophysiology Patient Care and Procedural Success in the EP Lab COMMERCIAL SUPPORT This continuing medical education activity is supported in part with educational
More informationLehigh University Team biographies. October 30, 2017
Lehigh University Team biographies October 30, 2017 Core team members 2 Lane McBride Partner and Managing Director, Washington, DC Lane McBride is a Partner and Managing Director in the Washington, D.C.
More informationB20 Health Conference Stepping Up Global Health Towards Resilient, Responsible, and Responsive Health Systems
B20 Health Conference Stepping Up Global Health Towards Resilient, Responsible, and Responsive Health Systems May 18 th, 2017 Location: Gasometer, EUREF-Campus 17, 10829 Berlin Conference Agenda (as of
More informationComprehensive Research Services
Comprehensive Research Services Scripps Health: At the Forefront of Clinical Research Scripps Health is a recognized leader in clinical research and has long been at the forefront of numerous medical breakthroughs.
More informationCardiac Safety Research Consortium: A Decade of CSRC. Mitchell W. Krucoff, MD, FACC
Cardiac Safety Research Consortium: A Decade of CSRC Mitchell W. Krucoff, MD, FACC Professor, Medicine/Cardiology Duke University Medical Center Director, Cardiovascular Devices Unit Co-Director, CSRC
More informationPatent Documentation Group
Patent Documentation Group 1957-2008 Minoo Philipp President Patent Documentation Group http://www.p-d-g.org Patents are a very important source of technical information Need for abstracts of patent information
More informationSharing Clinical Research Data: An Institute of Medicine Workshop
Forum on Drug Discovery, Development, and Translation Forum on Neuroscience and Nervous System Disorders National Cancer Policy Forum Roundtable on Translating Genomic-Based Research for Health Sharing
More informationManaging Conflict of Interest
Managing Conflict of Interest The Challenge of Pharmaceutical Company Marketing to Medical Professionalism David J. Rothman, Ph.D. Bernard Schoenberg Professor of Social Medicine Columbia College of Physicians
More informationThe importance of transnational corporations in research and development activities in the world
Jagiellonian Journal of Management vol. 3 (2017), no. 2, pp. 65 75 doi:10.4467/2450114xjjm.17.005.7735 www.ejournals.eu/jjm The importance of transnational corporations in research and development activities
More informationExperiences of an aspiring young scientist-entrepreneur
Experiences of an aspiring young scientist-entrepreneur Francis W. Hunter Auckland Cancer Society Research Centre Spark Entrepreneurship Challenge Mesopharm Therapeutics, Inc. 5 May 2014 Background Auckland
More informationABOUT THE SPEAKER. J. Roderick Heller, III
ABOUT THE SPEAKER J. Roderick Heller, III J. Roderick Heller, III, is President and Chief Executive Officer of the National Corporation for Housing Partnerships, a Congressionally authorized entity created
More informationTHE BUSINESS OF THE BRAIN 2.0 ACCELERATING PROGRESS TOWARD CURES
THE BUSINESS OF THE BRAIN 2.0 ACCELERATING PROGRESS TOWARD CURES Join us for a very special program co-hosted the HBS Alumni of Boston (HBSAB), The Harvard Stem Cell Institute (HSCI), and the Harvard NeuroDiscovery
More informationHFMA Summer Conference
HFMA Summer Conference August 11, 2017 Intermountain Lake Park Facility 4646 Lake Park Blvd Salt Lake City, Utah 84120 7.0 CPE hours 7:30 8:15 a.m. Continental Breakfast 8:15 8:30 a.m. Opening and Chapter
More informationBiotech Concerto #6 Investment Process December 2008
Biotech Concerto #6 Investment Process December 2008 Index Biotech Investment Characteristics Investment Policy Investment Team Scientific Advisory Board Deal Flow Attrition Rate From Screening to Decision
More informationBaxter 2007 Investor Conference March 14, 2007
Joy A. Amundson is a corporate vice president of Baxter Healthcare Corporation and president of the company s BioScience business. In this position, she is responsible for the development and worldwide
More informationSeminars in Health Care,
Seminars in Health Care, 2004-05 Welcome Welcome to the Health Sector Management seminar series. We are proud of the distinguished group that we have scheduled to speak. We hope that you find the speakers
More informationLIGAND PHARMACEUTICALS INCORPORATED (Exact Name of Registrant as Specified in Its Charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event
More informationMARKUSH FOR PATENT ANALYSIS. Steve Hajkowski ChemAxon UGM Budapest 2013
MARKUSH FOR PATENT ANALYSIS Steve Hajkowski ChemAxon UGM Budapest 2013 THOMSON REUTERS MARKUSH DATA Indexing for 2.4 million patent families 1.6m Markush structures, re-drawn & stored in Thomson Reuters
More informationThe 2010 EU industrial R&D investment SCOREBOARD
1 The 2010 EU industrial R&D investment SCOREBOARD Joint Research Centre European Commission Héctor Hernández 2 Contents 1. Background 2. Overall R&D trends 3. Top R&D companies 4. R&D by region 5. R&D
More informationOfficer Director etc. Ownership Partnership Principal. Speaker's Bureau
ACC.14 and TCT@ACC-i2 Program Committees' Disclosures of Relationships with Industry Moniring Last Abbott J. Dawn YES YES Pfizer Bosn scientific Adams David H. YES YES Medtronic, Edwards Lifesciences,
More informationACC.18 ABSTRACT REVIEWERS Disclosures
Name A. Michael Lincoff, M.D., FACC RESEARCH/RESEARCH GRANTS - AbbVie, Inc., Amgen, Astra Zeneca, Cerenis, CSL Behring, Edwards Lifesciences, Esperion, Ethicon, Infraredx, Janssen, Johnson & Johnson, Lilly,
More informationBOARD OF DIRECTORS. PETER WEHRLY Chair
BOARD OF DIRECTORS PETER WEHRLY Chair Peter Wehrly is the former group president of developed markets at Covidien, the manufacturer of medical devices with sales of over $10.7 billion (2014). Peter held
More informationMANAGING DIRECTOR 360 MADISON AVENUE NEW YORK, NY
Matthew Goldreich MANAGING DIRECTOR MGOLDREICH@CAINBROTHERS.COM 360 MADISON AVENUE NEW YORK, NY 10017 212.981.6946 Matt joined Cain Brothers in 1995 and is one of the longest tenured bankers at the firm.
More informationDISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
Controversies and Advances in the Treatment of Cardiovascular Disease The Sixteenth in the Series November 17 & 18, 2016 Montage Beverly Hills DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS In accordance
More informationRichard J. Donoghue Senior Vice President for Strategy, Planning and Business Development
Richard J. Donoghue Senior Vice President for Strategy, Planning and Business Development Richard (Rick) J. Donoghue, senior vice president for strategy, planning and business development at NYU Langone
More informationLife Sciences CONFERENCE SERIES. Business Information in a Global Context LIFE SCIENCES IP PORTFOLIO. Business Development Pack
C5 Business Information in a Global Context Life Sciences CONFERENCE SERIES LIFE SCIENCES IP PORTFOLIO Business Development Pack C5 GROUPS LIFE SCIENCES EVENTS Pharmaceuticals, biotechnology, diagnostics,
More informationAnnual Press Conference Financial year 2017
Annual Press Conference 2018 Financial year 2017 Financial year Hubertus von Baumbach Chairman of the Board of Managing Directors 2017 Highly successful financial year 2017 Major success with human pharmaceuticals
More informationYevo Scientific Advisory Board
TM Yevo Scientific Advisory Board Dr. Stacey J. Bell Head of the Yevo Scientific Advisory Board Dr. Stacey Bell has been a nutritional consultant from 2008 to 2014, when she joined Yevo International.
More informationCONFE R E NC E AG E NDA
CONFE R E NC E AG E NDA A DVA MED PAYMENT POL ICY As the reimbursement and coverage landscapes for the medical technology industry are continuously changing, s 4th Annual Payment Policy Conference will
More informationLIGHTHOUSE. The Science of Pharmaceutical Manufacturing
The Science of Pharmaceutical Manufacturing The Power of headspace inspection insight into the process. On the other hand, rapid non-destructive headspace analysis from is a powerful analytical tool for
More informationMonetizing Early-Stage R&D Assets. March 18, 2015
Monetizing Early-Stage R&D Assets March 18, 2015 Disclaimer Ernst & Young refers to the global organization of member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst
More informationManagement Team. Bruce C. Cozadd Chairman and Chief Executive Officer
Bruce C. Cozadd Chairman and Chief Executive Officer Bruce Cozadd joined Jazz Pharmaceuticals at its inception and was appointed Jazz Pharmaceuticals Chief Executive Officer in April 2009. From 2003 until
More informationINSTITUTE OF MEDICINE COMMITTEE ON THE U.S. COMMITMENT TO GLOBAL HEALTH
INSTITUTE OF MEDICINE COMMITTEE ON THE U.S. COMMITMENT TO GLOBAL HEALTH Sharing Information, Knowledge and Materials Dr. Ashley J. Stevens Executive Director, Technology Transfer Senior Research Associate
More informationPage 1 of 305. ACC.13 Presenter Disclosures of Relationships with Industry Officer Director etc.
ACC.13 Presenter Disclosures of Relationships with Industry Last First Aaronson Alistair Aaronson Keith D. YES HeartWare Thoratec, HeartWare Ababneh Bashar Abagriy A YES Lectures for Nycomed, Pfizer, Servier,
More informationCarolinas HealthCare Foundation. Annual Report 2016
Carolinas HealthCare Foundation Annual Report 2016 Today, multiple programs and services throughout Carolinas HealthCare System are being supported or significantly enhanced by philanthropy. Children s
More informationResearched Medicines Industry Association of New Zealand Incorporated
MResearched Medicines Industry Researched Medicines Industry Association of New Zealand Incorporated Submission on Patents Bill to the Commerce Select Committee July 2009 Researched Medicines Industry
More informationUsing Academic Licensing Agreements to Promote Global Social Responsibility
Using Academic Licensing Agreements to Promote Global Social Responsibility Equitable Licensing of Medical Research Results Charité - Universitätsmedizin Berlin April 26, 2009 Dr. Ashley J. Stevens Executive
More informationMid-Atlantic - Russia Business Council (MARBC)
MARBC Mid-Atlantic - Russia Business Council (MARBC) 16 th Semi-Annual Russian-American Innovation Technology Weeks (RANIT-BIO) Agenda June 14-21, 2012 Philadelphia, PA Boston, MA The 16 th Semi-Annual
More information2018 Annual Liver Meeting November 9-13, 2018 San Francisco, CA
Learner Notification 2018 Annual Liver Meeting November 9-13, 2018 San Francisco, CA Acknowledgement of Financial Commercial Support No financial commercial support was received for this educational activity.
More informationSan Diego. March 2, American College of Surgeons Surgical Health Care Quality Forum. American College of Surgeons
American College of Surgeons Inspiring Quality: Highest Standards, Better Outcomes American College of Surgeons Surgical Health Care Quality Forum San Diego March 2, 2012 Scripps Memorial Hospital La Jolla
More informationWINTER FRIDAY ~ SUNDAY, 10 ~ 12 JANUARY Department of Surgery University of Hong Kong Medical Centre Queen Mary Hospital Hong Kong
WINTER FRIDAY ~ SUNDAY, 10 ~ 12 JANUARY 2003 Department of Surgery University of Hong Kong Medical Centre Queen Mary Hospital Hong Kong HONG KONG SURGICAL FORUM The Hong Kong Surgical Forum is an international
More informationCurriculum Vita. Paul H. Keckley, Ph.D. Career Focus: Expert on health system transformation. Career History: Current:
Curriculum Vita Paul H. Keckley, Ph.D. Career Focus: Expert on health system transformation Career History: Current: Managing Editor, The Keckley Report (2006-present) The Keckley Report is a weekly blog
More information2,500,000 Shares. Common Stock
Filed Pursuant to Rule 424(b)(3) Registration Statement No. 333-201841 Prospectus Supplement No. 15 to Prospectus dated February 26, 2015 2,500,000 Shares Common Stock This Prospectus Supplement No. 15
More informationThe Role of Patients in Transitions of Care
Play an Active Role It is crucial that you play an active role in your own healthcare. During treatment, you may see more than one provider. You also may visit more than one care setting. In each case,
More informationForm FI. Management s Discussion and Analysis of Results of Operations and Financial condition for the six months ended April 30, 2007.
Form 51-102FI SERNOVA CORP. Management s Discussion and Analysis of Results of Operations and Financial condition for the six months ended April 30, 2007. The following discussion and analysis should be
More informationGiuseppe Savoja Curriculum Vitae mob.: Past
International Marketing Manager at Medtronic Geneva Area, Switzerland, Medical Devices Past Marketing Program Manager International Surgical Ablation & Beating Heart Revascularization at Medtronic Product
More informationHealthcare and Life Sciences Group MERGERS & ACQUISITIONS
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Sullivan & Cromwell LLP 2013 LG4690 Prior results do not guarantee a similar outcome. Through decades of experience in many of the transactions
More informationManagement to Host Conference Call at 8:30 a.m. ET today
Aclaris Therapeutics Reports Second Quarter 2016 Financial Results August 11, 2016 7:01 AM ET Management to Host Conference Call at 8:30 a.m. ET today MALVERN, Pa., Aug. 11, 2016 (GLOBE NEWSWIRE) -- (NASDAQ:ACRS),
More informationCASI Pharmaceuticals, Inc.
CASI Pharmaceuticals, Inc. Your Strategic Drug Development Partner in China NASDAQ: CASI WWW.CASIPHARMACEUTIALS.COM Forward Looking Statements This presentation contains forward-looking statements within
More informationRICHARD BUTLAND Director
RICHARD BUTLAND Richard Butland is the managing partner of Kite Capital, a growth oriented private investment firm. Prior to establishing Kite Capital, Richard spent 15 years at Goldman Sachs where he
More informationSPONSORSHIP 2009 guide
SPONSORSHIP 2009guide Prix Galien USA Committee The Prix Galien Award recognizes outstanding achievements in improving the global human condition through the development of innovative therapies. The Prix
More informationBuilding quality into HTA and Coverage Decision- Making Processes: What are the features of good practice in HTA?
Workshop on Building quality into HTA and Coverage Decision- Making Processes: What are the features of good practice in HTA? 2 nd & 3 rd December 2013 Sheraton Heathrow Airport Hotel, UK PROGRAMME Organisers:
More informationChairman Estrada asked the Secretary to call upon the registered public speakers. The Secretary called upon the following registered speaker:
Minutes of the meeting of the Finance Committee of the Board of Directors of the Cook County Health and Hospitals System held Thursday, February 15, 2018 at the hour of 8:30 A.M., at 1900 W. Polk Street,
More informationGreg Gubitz CEO Gilbert Godin President & COO Winter 2018
INVESTOR PRESENTATION Greg Gubitz CEO Gilbert Godin President & COO Winter 2018 Forward-looking statements Certain statements in this presentation are forward-looking statements. Any statements that express
More informationHealthcare and Life Sciences Group MERGERS & ACQUISITIONS
Healthcare and Life Sciences Group MERGERS & ACQUISITIONS Through decades of experience in many of the transactions that have defined the healthcare and life sciences industry, Sullivan & Cromwell offers
More informationPlease join us as a committed sponsor to make the NC CEO Forum as spectacular, educational and enjoyable as ever. We can t do this without you!
INVITATION TO SPONSOR Currently in its eighth year, the North Carolina CEO Forum is an invitation-only leadership event that welcomes 400 senior business, government and non-profit leaders who are committed
More informationJOHN JACK R. TUPMAN, JR CURRICULUM VITAE
JOHN JACK R. TUPMAN, JR CURRICULUM VITAE September 2018 John R. Tupman, Jr. is a consultant focused on business development and licensing in the life sciences industry. He is currently working as a consultant
More informationROLL CALL PURCHASE RECOMMENDATIONS
13 Board Meeting September 7, 2017 ROLL CALL PURCHASE RECOMMENDATIONS The "Purchase Recommendations" are presented by campus and a Summary from "Appropriated Funds" (i.e., from State appropriations to
More information30th Annual Oncology Nurses Symposium
E X H I B I T O R P R O S P E C T U S 30th Annual Oncology Nurses Symposium S E P T E M B E R 2 6-2 9, 2 0 1 0 H I L T O N S A N D I E G O R E S O R T Scripps Conference Services & CME www.scripps.org/conferenceservices
More information